INTERNATIONAL PATENT: CRISPR THERAPEUTICS AG FILES APPLICATION FOR "MODULATING EXPRESSION OF ALAS1 (5'-AMINOLEVULINATE SYNTHASE 1) GENE"

GENEVA, Feb. 3 -- CRISPR THERAPEUTICS AG (Baarerstrasse 146300 Zug) filed a patent application (PCT/IB2024/057065) for "MODULATING EXPRESSION OF ALAS1 (5'-AMINOLEVULINATE SYNTHASE 1) GENE" on Jul 21, 2024. With publication no. WO/2025/022290, the details related to the patent application was published on Jan 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DEQUEANT, Mary-Lee (105 West First StreetSouth Boston, Massachusetts 02127), HEATH, Heidi (105 West First StreetSouth Boston, Massachusetts 02127), YUEN, Rachel (105 West First StreetSouth Boston, Massachusetts 02127)

Abstract: The p...